Oxford BioMedica PLC (OXBDF)
3.79
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Oxford BioMedica Market Cap: 379.00M for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 379.00M |
| May 03, 2024 | 379.00M |
| May 02, 2024 | 379.00M |
| May 01, 2024 | 291.00M |
| April 30, 2024 | 291.00M |
| April 29, 2024 | 291.00M |
| April 26, 2024 | 291.00M |
| April 25, 2024 | 282.00M |
| April 24, 2024 | 272.00M |
| April 23, 2024 | 263.23M |
| April 22, 2024 | 253.55M |
| April 19, 2024 | 253.07M |
| April 18, 2024 | 253.07M |
| April 17, 2024 | 253.07M |
| April 16, 2024 | 253.07M |
| April 15, 2024 | 253.07M |
| April 12, 2024 | 253.07M |
| April 11, 2024 | 253.07M |
| April 10, 2024 | 254.04M |
| April 09, 2024 | 254.04M |
| April 08, 2024 | 254.04M |
| April 05, 2024 | 254.04M |
| April 04, 2024 | 236.13M |
| April 03, 2024 | 236.13M |
| April 02, 2024 | 235.16M |
| Date | Value |
|---|---|
| April 01, 2024 | 235.16M |
| March 28, 2024 | 235.16M |
| March 27, 2024 | 235.16M |
| March 26, 2024 | 235.16M |
| March 25, 2024 | 240.00M |
| March 22, 2024 | 238.07M |
| March 21, 2024 | 238.07M |
| March 20, 2024 | 232.26M |
| March 19, 2024 | 232.26M |
| March 18, 2024 | 232.26M |
| March 15, 2024 | 236.13M |
| March 14, 2024 | 248.52M |
| March 13, 2024 | 248.52M |
| March 12, 2024 | 263.23M |
| March 11, 2024 | 263.23M |
| March 08, 2024 | 263.23M |
| March 07, 2024 | 263.23M |
| March 06, 2024 | 240.15M |
| March 05, 2024 | 241.94M |
| March 04, 2024 | 210.00M |
| March 01, 2024 | 210.97M |
| February 29, 2024 | 210.97M |
| February 28, 2024 | 210.97M |
| February 27, 2024 | 210.97M |
| February 26, 2024 | 210.97M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
202.26M
Minimum
Feb 22 2024
1.889B
Maximum
Sep 23 2021
752.54M
Average
628.81M
Median
Feb 06 2020
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 266.57M |
| Biodexa Pharmaceuticals Plc | 4.385M |
| Verona Pharma PLC | 1.203B |
| NuCana PLC | 8.183M |
| Autolus Therapeutics PLC | 1.080B |
Market Cap Related Metrics
| PS Ratio | 3.278 |
| Price to Book Value | 4.020 |
| Price | 3.79 |
| Earnings Yield | -53.58% |